Skip to main content
. Author manuscript; available in PMC: 2023 Mar 17.
Published in final edited form as: Lancet Haematol. 2018 Dec;5(12):e618–e627. doi: 10.1016/S2352-3026(18)30176-5

Table 1:

Patient characteristics

All patients (N=76)

Age, years 47 (39–61)
 ≥50 35 (46%)
 ≥60 20 (26%)
Eastern Cooperative Oncology Group Performance status
 0–1 68 (89%)
 2 8 (11%)
White blood cells (x 109 per L) 13.6 (26–76.6
CNS disease 5 (7%)
CD20 positivity 26 (34%)
BCR-ABL1 transcript
 p190 56 (74%)
 p210 19 (25%)
Cytogenetics
 Diploid 21 (28%)
 Philadelphia chromosome-positive 55 (72%)
Baseline cardiovascular risk factors
 Hypertension 29 (38%)
 Diabetes 13 (17%)
 Dyslipidaemia 8 (11%)
 Coronary artery disease 6 (8%)
 Peripheral arterial disease 1 (1%)
Number of cardiovascular risk factors
 1 22 (29%)
 2 7 (9%)
 3 5 (7%)
 ≥4 1 (1%)
Data are median (IQR) or n (%).